The most abundant components of living cells are proteins and peptides. Protein and Peptide are both novel medication delivery systems and novel drug delivery approaches. Peptides can be created to target a wide spectrum of molecules, allowing them to be used in fields as diverse as oncology, immunology, infectious illness, and endocrinology. While the market for peptide and protein therapeutics has grown dramatically in recent decades, their availability has been limited. Peptides and proteins have a lot of therapeutic potential. The market for peptide and protein therapeutics is currently estimated to be worth more than $40 billion per year, accounting for 10% of the total pharmaceutical market. This market is increasing at a far quicker rate than that of small molecules, and it will soon account for a much higher share of the market.
Title : Mucoadhesive electrospun fibrous systems for the fast and sustained delivery of drugs
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Pharmaceutics 2023, Singapore, Abstract Pathology and Patient Safety: The Vital Role of Electronic Medical Record and Pathology Informatics in Error Reduction and Precision Medicine
Consolato M Sergi, University of Ottawa, Canada
Title : Values based practice and the impact on Drug discovery, regulation of the Pharma industry and consent in healthcare”
Ashok Handa, Collaborating Centre for Values Based Practice, United Kingdom